Title:Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
Volume: 17
Issue: 8
Author(s): Mark Walsh, Stephanie Fritz, Daniel Hake, Michael Son, Sarah Greve, Manar Jbara, Swetha Chitta, Braxton Fritz, Adam Miller, Mary K Bader, Jonathon McCollester, Sophia Binz, Alyson Liew-Spilger, Scott Thomas, Anton Crepinsek, Faisal Shariff and Victoria Ploplis, Francis J. Castellino
Affiliation:
关键词:
凝血弹性描记法,point-of-care,获得性凝血功能障碍,血液成分治疗,全身性止血剂,创伤引起的凝血功能障碍,止血复苏,氨甲环酸,靶向药物治疗。
摘要: Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally
has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international
normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen
levels. The varying sensitivity and specificity of these CCTs have led trauma coagulation researchers
and clinicians to use Viscoelastic Tests (VET) such as Thromboelastography (TEG) to provide Targeted Thromboelastographic
Hemostatic and Adjunctive Therapy (TTHAT) in a goal directed fashion to those trauma patients in need of hemostatic
resuscitation. This review describes the utility of VETs, in particular, TEG, to provide TTHAT in trauma and acquired
non-trauma-induced coagulopathy.